Publications by authors named "Yuzo Fujino"

The Dementia Screening Questionnaire for Individuals with Intellectual Disabilities (DSQIID) is an appropriate screening tool for detecting dementia in Down's syndrome patients. However, whether this questionnaire reflects the neuropsychiatric signs of biomarker-confirmed Alzheimer's disease in DS (DS-AD) remains unknown. To address this issue, we compared the plasma phosphorylated tau (P181tau: p-tau) level of a representative AD biomarker with the total score and each sub-score of the DSQIID.

View Article and Find Full Text PDF
Article Synopsis
  • A study was conducted on 46 adults with Down syndrome (DS), aged 15-58, to examine social maturity and changes over time using a specific social maturity test.
  • It was found that individuals under 20 and over 42 years old showed a lower social age (SA), with the lowest scores in the Socialization domain, consistent across all ages.
  • The decline in SA was more pronounced in those with Down syndrome and Alzheimer's disease (DS-AD), highlighting the need for better diagnostic methods for this group in the future.
View Article and Find Full Text PDF
Article Synopsis
  • TDP-43 aggregation in neurons is a key feature of ALS and FTD, but the mechanisms behind its formation are still unclear.
  • A study reveals that a lack of DCTN1 disrupts stress granule dynamics, leading to increased TDP-43 aggregation in cells and worsening neurodegeneration in live models.
  • Genetic knockdown of DCTN1 and other motor protein components also enhances TDP-43 inclusions, suggesting that issues with microtubule transport significantly influence TDP-43 pathology and stress granule behavior.
View Article and Find Full Text PDF

Tandem GGGGCC repeat expansion in C9orf72 is a genetic cause of frontotemporal lobar degeneration (FTLD) and amyotrophic lateral sclerosis (ALS). Transcribed repeats are translated into dipeptide repeat proteins via repeat-associated non-AUG (RAN) translation. However, the regulatory mechanism of RAN translation remains unclear.

View Article and Find Full Text PDF
Article Synopsis
  • - Abnormal expansions of the GGGGCC repeat sequence in noncoding regions are linked to familial amyotrophic lateral sclerosis and frontotemporal dementia, known as C9-ALS/FTD.
  • - Dipeptide repeat proteins (DPRs) from this expansion play a key role in disease progression, and the study investigates the regulatory effects of RNA-binding proteins (RBPs) on RAN translation related to these repeats.
  • - The research finds that the RBP FUS can suppress RAN translation and neurodegeneration by directly binding to the GGGGCC repeat RNA and influencing its G-quadruplex structure, offering potential therapeutic avenues for C9-ALS/FTD and similar diseases. *
View Article and Find Full Text PDF

There is ample epidemiological and animal-model evidence suggesting that intestinal inflammation is associated with the development of Parkinson's disease (PD). Leucine-rich α2 glycoprotein (LRG) is a serum inflammatory biomarker used to monitor the activity of autoimmune diseases, including inflammatory bowel diseases. In this study, we aimed to investigate whether serum LRG could be used a biomarker of systemic inflammation in PD and to help distinguish disease states.

View Article and Find Full Text PDF

Expanded short tandem repeats cause more than 50 monogenic diseases, which are mostly neuromuscular diseases. In the non-coding repeat expansion diseases, in which the expanded repeat sequence is located outside of the coding region, the toxicity of the transcribed repeat-containing RNAs had been the focus of research. However, recent studies have revealed that repeat RNAs can be translated into repeat polypeptides, despite the lack of an AUG initiation codon, by non-canonical repeat-associated non-AUG translation (RAN translation).

View Article and Find Full Text PDF

Expanded short tandem repeats in the genome cause various monogenic diseases, particularly neurological disorders. Since the discovery of a CGG repeat expansion in the FMR1 gene in 1991, more than 40 repeat expansion diseases have been identified to date. In the coding repeat expansion diseases, in which the expanded repeat sequence is located in the coding regions of genes, the toxicity of repeat polypeptides, particularly misfolding and aggregation of proteins containing an expanded polyglutamine tract, have been the focus of investigation.

View Article and Find Full Text PDF

Background: Impaired bioenergetics are partially involved in the pathogenesis of Parkinson's disease (PD). Phosphoglycerate kinase (PGK), an essential enzyme for glycolysis, has recently attracted attention due to its pathogenic role in PD and as a target for disease-modifying therapies. This study is aimed to evaluate the profiles of PGK activity in red blood cells (RBCs) of PD patients and controls.

View Article and Find Full Text PDF

Progressive encephalomyelitis with rigidity and myoclonus (PERM) is a severe form of stiff-person spectrum disorder characterized by painful spasms, myoclonic jerks, hyperekplexia, brainstem dysfunction, and dysautonomia, which is sometimes resistant to γ-amino-butyric acid (GABA)-ergic agents. The response to immunotherapy varies depending on identified autoantibodies. We report a dramatic response to dexmedetomidine in a patient with glycine receptor (GlyR) antibody-positive PERM who developed intractable clusters of myoclonic jerks and paroxysmal sympathetic hyperactivity (PSH) that was highly refractory to conventional symptomatic treatment with GABAergic drugs and immunotherapy.

View Article and Find Full Text PDF

Leukoencephalopathy with high-intensity signals in the corticomedullary junction on diffusion-weighted imaging (DWI) is a diagnostic hallmark for neuronal intranuclear inclusion disease (NIID). We herein report a 65-year-old man who developed dementia and was diagnosed with NIID 2 years later. Of note, he had coincidentally undergone brain magnetic resonance imaging 14 and 10 years before the onset of dementia.

View Article and Find Full Text PDF

The worsening of neuropsychiatric symptoms such as depression, anxiety, and insomnia in patients with Parkinson's disease (PD) has been a concern during the COVID-19 pandemic, because most people worked in self-isolation for fear of infection. We aimed to clarify the impact of social restrictions imposed due to the COVID-19 pandemic on neuropsychiatric symptoms in PD patients and to identify risk factors associated with these symptoms. A cross-sectional, hospital-based survey was conducted from April 22, 2020 to May 15, 2020.

View Article and Find Full Text PDF

Arterial and venous thrombi can coexist without preexisting conditions, such as malignant disease, thrombotic predisposition, or arteriovenous shunt. We herein report a case of acute cerebral infarction and pulmonary thromboembolism in the absence of underlying disease. A 71-year-old woman presented with left hemiplegia.

View Article and Find Full Text PDF

We report a 54-year-old man, who presented with an acute onset of diplopia and ptosis on the left side. On admission, neurological examination showed left oculomotor and abducens nerve palsy. Brain MRI showed thickening of the left parieto-temporal dura mater with gadolinium enhancement.

View Article and Find Full Text PDF